Imatinib/Rapamycin mRNA abundance
Source: NCBI BioProject (ID PRJNA156189)

0 0

Project name: Mus musculus
Description: Measurement of mRNA abundance from the following cells lines (red) versus universal mouse reference RNA (green). Wildtype v-Abl transformed pre-B cells were treated for 12 hours with 2.5 uM imatinib mesylate, 10ng/mL rapamycin or nothing.Compound Based Treatment: wildtype v-Abl transformed pre-B cells were treated with imatinib mesylate (IMA), rapamycin (RAP) or nothing (NONE)Overall design: compound_treatment_design
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: ModelOrganism
Organization: Patrick O. Brown, Biochemistry, Stanford U.
Last updated: 2012-01-11